AU5495798A - External preparations for percutaneous absorption - Google Patents

External preparations for percutaneous absorption

Info

Publication number
AU5495798A
AU5495798A AU54957/98A AU5495798A AU5495798A AU 5495798 A AU5495798 A AU 5495798A AU 54957/98 A AU54957/98 A AU 54957/98A AU 5495798 A AU5495798 A AU 5495798A AU 5495798 A AU5495798 A AU 5495798A
Authority
AU
Australia
Prior art keywords
percutaneous absorption
external preparations
preparations
external
percutaneous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU54957/98A
Inventor
Kazushi Ito
Tadao Kawamori
Kiyoshi Kuriyama
Masanori Matsuda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sekisui Chemical Co Ltd
Original Assignee
Sekisui Chemical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sekisui Chemical Co Ltd filed Critical Sekisui Chemical Co Ltd
Publication of AU5495798A publication Critical patent/AU5495798A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
AU54957/98A 1997-01-16 1998-01-16 External preparations for percutaneous absorption Abandoned AU5495798A (en)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
JP551697 1997-01-16
JP9-5516 1997-01-16
JP9-72294 1997-03-25
JP7229497 1997-03-25
JP34799997 1997-12-17
JP9-347999 1997-12-17
PCT/JP1998/000123 WO1998031369A1 (en) 1997-01-16 1998-01-16 External preparations for percutaneous absorption

Publications (1)

Publication Number Publication Date
AU5495798A true AU5495798A (en) 1998-08-07

Family

ID=27276790

Family Applications (1)

Application Number Title Priority Date Filing Date
AU54957/98A Abandoned AU5495798A (en) 1997-01-16 1998-01-16 External preparations for percutaneous absorption

Country Status (2)

Country Link
AU (1) AU5495798A (en)
WO (1) WO1998031369A1 (en)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3993169B2 (en) 2002-02-11 2007-10-17 アンタレス・ファーマ・インコーポレーテッド Intradermal syringe
ES2908027T3 (en) 2005-01-24 2022-04-27 Antares Pharma Inc An injector with a pre-filled syringe
US8251947B2 (en) 2006-05-03 2012-08-28 Antares Pharma, Inc. Two-stage reconstituting injector
US9144648B2 (en) 2006-05-03 2015-09-29 Antares Pharma, Inc. Injector with adjustable dosing
EP2990067B1 (en) 2008-03-10 2019-09-04 Antares Pharma, Inc. Injector safety device
EP3581224A1 (en) 2008-08-05 2019-12-18 Antares Pharma, Inc. Multiple dosage injector
CN102612381B (en) 2009-03-20 2015-09-09 安塔瑞斯制药公司 Hazardous agents injected system
US8491927B2 (en) * 2009-12-02 2013-07-23 Nimble Epitech, Llc Pharmaceutical composition containing a hypomethylating agent and a histone deacetylase inhibitor
US8496619B2 (en) 2011-07-15 2013-07-30 Antares Pharma, Inc. Injection device with cammed ram assembly
US9220660B2 (en) 2011-07-15 2015-12-29 Antares Pharma, Inc. Liquid-transfer adapter beveled spike
PT2822618T (en) 2012-03-06 2024-03-04 Antares Pharma Inc Prefilled syringe with breakaway force feature
EP4186545A1 (en) 2012-04-06 2023-05-31 Antares Pharma, Inc. Needle assisted jet injection administration of testosterone compositions
WO2013169800A1 (en) 2012-05-07 2013-11-14 Antares Pharma, Inc. Injection device with cammed ram assembly
EP2953667B1 (en) 2013-02-11 2019-10-23 Antares Pharma, Inc. Needle assisted jet injection device having reduced trigger force
JO3516B1 (en) 2013-03-06 2020-07-05 Janssen Pharmaceutica Nv Benzoimidazol-2-yl pyrimidine modulators of the histamine h4 receptor
WO2014164786A1 (en) 2013-03-11 2014-10-09 Madsen Patrick Dosage injector with pinion system
WO2014165136A1 (en) 2013-03-12 2014-10-09 Antares Pharma, Inc. Constant volume prefilled syringes and kits thereof
CN110139641B (en) * 2016-12-28 2022-09-09 富士胶片富山化学株式会社 External composition

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE70444T1 (en) * 1986-05-30 1992-01-15 Univ California TOPICAL METHOTREXATE PREPARATION FOR THE TREATMENT OF HYPERPROLIFERATIVE EPITHELIAL DISEASES.
EP0958355A1 (en) * 1996-07-23 1999-11-24 Wilson Trafton Crandall Transdermal transport of molecules

Also Published As

Publication number Publication date
WO1998031369A1 (en) 1998-07-23

Similar Documents

Publication Publication Date Title
AU6122999A (en) Sorbefacients and preparations for percutaneous absorption containing the same
AU1151099A (en) Azaoxindole derivatives
AU1825899A (en) Dota-biotin derivatives
AU7935398A (en) Diaminorhodamine derivatives
AUPM434594A0 (en) Canopy
AU6117998A (en) 3-oxadiazolylquinoxaline derivatives
AU5495798A (en) External preparations for percutaneous absorption
AU7069198A (en) Collimator
AUPO688997A0 (en) Sunscreen composition
AU6804098A (en) Triazinylaminostilbene compounds
AU3089199A (en) Preparations containing licariin
AU9663498A (en) Sunscreen composition
EP1221315A4 (en) Ophthalmic adhesive preparations for percutaneous absorption
AU3536799A (en) Percutaneous preparations containing oxybutynin
AU4330097A (en) Pharmaceutical compounds
AU7813598A (en) Betulinol derivatives
EP0968710A4 (en) Patch preparations for percutaneous absorption
AUPP042397A0 (en) 5-arylpyrazole compounds
AU7124598A (en) Polymer-platinum compounds
AU6729498A (en) Thiazolimine derivatives
AU1174199A (en) Biphenylamidine derivatives
AU4169897A (en) Pharmaceutical compounds
AU1800100A (en) Medicinal preparations
AU8019998A (en) Fluoromethoximino compounds
AU1562199A (en) Amino-benzothiazole derivatives